Evidence item

Independent reporting explicitly distinguishes low-risk and high-risk control groups and gives their separate PANXEON false-positive rates. DIRECT_TEXT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 14273

Source: PANXEON Blood Test Detects Early Pancreatic Cancer · locator {} · excerpt hash sha256:012fac1f4074ee26a8d0c69f6ebcbf11bb01164eee95d598dd1f0d031f06cb5d

In the testing cohort, PANXEON had a false-positive rate of: 3.2% among low-risk controls; 15.6% among high-risk controls.